Cancer micrometastases

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nature Reviews Clinical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrclinonc.2009.44PMID 19399023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Detection of mutations in EGFR in circulating lung-cancer cells.

  2008cited by this paper
• Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope

  2008cited by this paper
• Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer.

  2008cited by this paper
• Mechanisms of Disease: cancer stem cells—targeting the evil twin

  2008cited by this paper
• Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.

  2008cited by this paper
• Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial

  2008cited by this paper
• Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

  2008cited by this paper
• Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables.

  2008cited by this paper
• Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

  2008cited by this paper
• Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.

  2008cited by this paper
• Detection of circulating cancer cells in lung cancer patients with a panel of marker genes.

  2008cited by this paper
• Cancer micrometastasis and tumour dormancy  

  2008cited by this paper
• Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

  2008cited by this paper
• Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer.

  2008cited by this paper
• Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse

  2008cited by this paper
• Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis

  2008cited by this paper
• Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy

  2008cited by this paper
• HER-2/neu expression in primary and metastatic breast cancer

  2008cited by this paper
• Detection, clinical relevance and specific biological properties of disseminating tumour cells

  2008cited by this paper
• Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

  2008cited by this paper
• Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

  2008cited by this paper
• The prognostic role of a gene signature from tumorigenic breast-cancer cells.

  2007cited by this paper
• Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance.

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Detection of Carcinoembryonic Antigen Messenger RNA-Expressing Cells in Peripheral Blood 7 Days After Curative Surgery is a Novel Prognostic Factor in Colorectal Cancer

  2007cited by this paper
• Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

  2007cited by this paper
• Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.

  2007cited by this paper
• Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

  2007cited by this paper
• Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.

  2007cited by this paper
• Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

  2007cited by this paper
• CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.

  2007cited by this paper
• Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

  2007cited by this paper
• Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

  2007cited by this paper
• Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies TWIST1 as a Marker of Early Tumor Relapse in Breast Cancer Patients

  2007cited by this paper
• Detection and characterization of putative metastatic precursor cells in cancer patients.

  2007cited by this paper
• Isolation of rare circulating tumour cells in cancer patients by microchip technology

  2007cited by this paper
• Adaptive immunity maintains occult cancer in an equilibrium state

  2007cited by this paper
• Models, mechanisms and clinical evidence for cancer dormancy

  2007cited by this paper
• Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.

  2007cited by this paper
• HER2 gene status in primary breast cancers and matched distant metastases

  2007cited by this paper
• Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.

  2007cited by this paper
• HER‐2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy

  2007cited by this paper
• Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes

  2007cited by this paper
• Prognostic Significance of Multiple Molecular Markers for Patients With Stage II Colorectal Cancer Undergoing Curative Resection

  2007cited by this paper
• American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

  2007cited by this paper
• Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer.

  2007cited by this paper
• The impact of nodal isolated tumor cells on survival of breast cancer patients.

  2007cited by this paper
• Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma

  2007cited by this paper
• Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients

  2007cited by this paper
• Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.

  2007cited by this paper
• Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer

  2006cited by this paper
• Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

  2006cited by this paper
• Tumor metastasis: mechanistic insights and clinical challenges

  2006cited by this paper
• High speed detection of circulating tumor cells.

  2006cited by this paper
• A European interlaboratory testing of three well‐known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow

  2006cited by this paper
• Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

  2006cited by this paper
• Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy

  2006cited by this paper
• Development of a membrane array‐based multimarker assay for detection of circulating cancer cells in patients with non‐small cell lung cancer

  2006cited by this paper
• Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining.

  2006cited by this paper
• Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.

  2006cited by this paper
• Stem cells and cancer: two faces of eve.

  2006cited by this paper
• Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype

  2006cited by this paper
• A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

  2006cited by this paper
• HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer Patients

  2006cited by this paper
• Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients

  2006cited by this paper
• Tumor cell detection in peripheral blood and bone marrow

  2006cited by this paper
• Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer

  2006cited by this paper
• Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer

  2006cited by this paper
• Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients

  2006cited by this paper
• Random mutations, selected mutations: A PIN opens the door to new genetic landscapes

  2006cited by this paper
• Biological Significance of Occult Micrometastases in Histologically Negative Axillary Lymph Nodes in Breast Cancer Patients Using the Recent American Joint Committee on Cancer Breast Cancer Staging System

  2006cited by this paper
• Combined Detection of CEA, CK-19 and c-met mRNAs in Peripheral Blood: A Highly Sensitive Panel for Potential Molecular Diagnosis of Non-Small Cell Lung Cancer

  2006cited by this paper
• Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.

  2006cited by this paper
• Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.

  2006cited by this paper
• uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

  2006cited by this paper
• Bone-marrow haematopoietic-stem-cell niches

  2006cited by this paper
• The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence

  2005cited by this paper
• Maintenance of long‐term tumour‐specific T‐cell memory by residual dormant tumour cells

  2005cited by this paper
• Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity

  2005cited by this paper
• Detection of Carcinoembryonic Antigen Messenger RNA–Expressing Cells in Portal and Peripheral Blood During Surgery Does Not Influence Relapse in Colorectal Cancer

  2005cited by this paper
• A pooled analysis of bone marrow micrometastasis in breast cancer.

  2005cited by this paper
• Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials

  2005cited by this paper
• Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.

  2005cited by this paper
• Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.

  2005cited by this paper
• Circulating tumor cells predict survival in patients with metastatic prostate cancer.

  2005cited by this paper
• Comparison of HER‐2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

  2005cited by this paper
• Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.

  2005cited by this paper
• Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients.

  2005cited by this paper
• Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells

  2005cited by this paper
• Surfactant protein gene expressions for detection of lung carcinoma cells in peripheral blood.

  2005cited by this paper
• Prognostic Significance of Baseline Reverse Transcriptase-PCR for Prostate-Specific Antigen in Men with Hormone-Refractory Prostate Cancer Treated with Chemotherapy

  2005cited by this paper
• VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

  2005cited by this paper
• Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

  2005cited by this paper
• Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients

  2004cited by this paper
• HER-2 gene amplification can be acquired as breast cancer progresses.

  2004cited by this paper
• Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse

  2004cited by this paper

• Sensitive Determination of Gemcitabine Molecule by Novel Magnetic Solid-Phase Extraction Coupled with HPLC-DAD

  2025cites this paper
• Precision Oncology Framework Using Circulating Tumor Cells

  2025cites this paper
• Dormant Tumor Cells: Current Opportunities and Challenges in Clinical Practice

  2025cites this paper
• ComplexDnet: A Network-Based Strategy to Discover Critical Targets and Screen Active Compounds for Complex Diseases.

  2025cites this paper
• EZH2 in Digestive System Cancers: Epigenetic Regulation, Oncogenic Interactions, and Therapeutic Potential.

  2025cites this paper
• The Glycosyltransferase XYLT1 Activates NF-κB Signaling to Promote Metastasis of Early-Stage Lung Adenocarcinoma.

  2025cites this paper
• Monte Carlo calculation of 119Sb microscale absorbed dose using cascaded and averaged Auger electron spectra

  2025influential citation
• Prognostic Value of Distant Micrometastasis in Breast Cancer: A Population-Based Propensity Score-Matched Study

  2025cites this paper
• Small cell size circulating tumor cells predict the prognosis of high-risk non-muscle invasive bladder cancer patients

  2025cites this paper
• Bioengineered human bone-mimetic niche compositions regulate breast cancer cell quiescence and therapy response

  2025cites this paper
• Enumeration, classification and clinical application of circulating tumor cells in advanced gallbladder adenocarcinoma

  2025cites this paper
• The concomitant tumor suspension cells derived from SKBR-3 exhibit circulating tumor cell features.

  2025cites this paper
• Potential utility of ADNP in circulating tumor cells as biomarker for prognostics in non-muscle-invasive bladder cancer

  2024cites this paper
• MicroFlow-Through Wool Cartridge for 3D Enrichment, Rapid Manipulation, and Label-Free Detection of Prostate Cancer Cells in Urine*

  2024influential citation
• Clinical impact of epithelial–mesenchymal transition for cancer therapy

  2024cites this paper
• Enrichment and separation technology for evaluation of circulating tumor cells.

  2024cites this paper
• Strategic aspect for improving the sensitivity of nanoparticles in biomedical sciences

  2024cites this paper
• A Genuinely Hybrid, Multiscale 3D Cancer Invasion and Metastasis Modelling Framework

  2024cites this paper
• Nerve Growth Factor Signaling Promotes Nuclear Translocation of TRAF4 to Enhance Tumor Stemness and Metastatic Dormancy Via C‐Jun‐mediated IL‐8 Autocrine

  2024cites this paper
• Precision Phenotypic Profiling and Capture of Circulating Tumor Cells via a Vertical Laminar Flow-Stacked Microfluidic Chip

  2024cites this paper
• Allicin: a promising modulator of apoptosis and survival signaling in cancer

  2024cites this paper
• Carcinoembryonic antigen-positive circulating epithelial cells as a biomarker for the diagnosis and prognosis of colorectal cancer

  2024cites this paper
• High-throughput and simultaneous inertial separation of tumor cells and clusters from malignant effusions using spiral-contraction-expansion channels

  2024cites this paper
• A multiple cancer cell optical biosensing metastructure realized by CPA.

  2024cites this paper
• Progress of the Study on Type III Collagen in Breast Cancer

  2024cites this paper
• GPRC5A promotes lung colonization of esophageal squamous cell carcinoma

  2024cites this paper
• Synthesis, in silico studies, and in vitro biological evaluation of newly-designed 5-amino-1H-tetrazole-linked 5-fluorouracil analog as a potential antigastric-cancer agent

  2024cites this paper
• Investigating the effect of LncRNA DLGAP1-AS2 suppression on chemosensitivity of gastric cancer to chemotherapy

  2024cites this paper
• Harnessing the power of Microscale AcoustoFluidics: A perspective based on BAW cancer diagnostics

  2024cites this paper
• Metastasis Models: Thermodynamics and Complexity.

  2024cites this paper
• Palliative surgery versus non-surgery of the solitary metastatic lesion in De novo metastatic breast cancer: A SEER based study

  2024cites this paper
• Predicting Microbe-Disease Association Based on Enhanced Relational Graph Convolutional Networks

  2024cites this paper
• Eco-friendly Synthesis of WO3 Nanostructures for Near-Infrared Laser Improved Photothermal Therapy of Breast Cancer

  2024cites this paper
• Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality

  2023cites this paper
• PLGA-based drug delivery systems in treating bone tumors

  2023cites this paper
• Laser transfer for circulating tumor cell isolation in liquid biopsy

  2023cites this paper
• Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis

  2023cites this paper
• Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors

  2023cites this paper
• An electrochemical biosensor based on network-like DNA nanoprobes for detection of mesenchymal circulating tumor cells.

  2023cites this paper
• Bifunctional bone substitute materials for bone defect treatment after bone tumor resection

  2023cites this paper
• ML-NPI: Predicting Interactions between Noncoding RNA and Protein Based on Meta-Learning in a Large-Scale Dynamic Graph

  2023cites this paper
• Circulating Tumor Cells are an Independent Risk Factor for Poor Prognosis in Patients with Gallbladder Adenocarcinoma

  2023cites this paper
• Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications.

  2023cites this paper
• Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction

  2023cites this paper
• Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients.

  2023cites this paper
• Enhanced prognostic value of combined circulating tumor cells and serum carcinoembryonic antigen in patients with colorectal cancer

  2023cites this paper
• NIR-II Imaging and Sandwiched Plasmonic Biosensor for Ultrasensitive Intraoperative Definition of Tumor-Invaded Lymph Nodes

  2023cites this paper
• Early detection of metastasis in ascites and peritoneal lavage - new perspectives using label-free microfluidic approaches.

  2023cites this paper
• New, fast and cheap prediction tests for BRCA1 gene mutations identification in clinical samples

  2023cites this paper
• Application of magnetic solid-phase extraction for sensitive determination of anticancer drugs in urine by means of diamino benzidine tetrachlorohydrate modified magnetic nanoparticles

  2023cites this paper
• The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients

  2023cites this paper
• Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with Colorectal Carcinoma

  2023cites this paper
• The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis

  2023cites this paper
• Preparation of a shared chip for cell capturing and imaging with nanoparticle scaffold, nanogap and circulating tumor cell detection.

  2023cites this paper
• Exploring the Three-Dimensional Frontier: Advancements in MSC Spheroids and Their Implications for Breast Cancer and Personalized Regenerative Therapies

  2023cites this paper
• Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study

  2023cites this paper
• Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling

  2022cites this paper
• Exosomes derived from bone marrow mesenchymal stem cells promote proliferation and migration via upregulation yes-associated protein/transcriptional coactivator with PDZ binding motif expression in breast cancer cells

  2022cites this paper
• Clinical significance of circulating tumor cell (CTC)-specific microRNA (miRNA) in breast cancer.

  2022cites this paper
• EMT status of circulating breast cancer cells and impact of fluidic shear stress.

  2022cites this paper
• Circulating Tumor Cells and Breast Cancer Metastasis: From Enumeration to Somatic Mutational Profile

  2022cites this paper
• Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells

  2022cites this paper
• Cancer metastasis chemoprevention prevents circulating tumour cells from germination

  2022cites this paper
• Emerging Technologies for the Detection of Cancer Micrometastasis

  2022cites this paper
• Longevity, Aging and Cancer: Thermodynamics and Complexity

  2022cites this paper
• Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes

  2022cites this paper
• The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma

  2022cites this paper
• Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma

  2022cites this paper
• Cancer Stem Cells And Anti-Tumor Immunity.

  2022cites this paper
• Fabrication of a Polyvalent Aptamer Network on an Electrode Surface for Capture and Analysis of Circulating Tumor Cells.

  2022cites this paper
• Development and validation of radiomics nomograms for preoperative prediction of characteristics in non-small cell lung cancer and circulating tumor cells

  2022cites this paper
• Nanomaterial-based biosensor developing as a route toward in vitro diagnosis of early ovarian cancer

  2022cites this paper
• Unraveling Cancer Metastatic Cascade Using Microfluidics-based Technologies

  2022cites this paper
• Acoustic bubble for spheroid trapping, rotation, and culture: a tumor-on-a-chip platform (ABSTRACT platform).

  2022cites this paper
• Single-cell sequencing and its applications in bladder cancer

  2022cites this paper
• Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer

  2022cites this paper
• Microfluidic harvesting of breast cancer tumor spheroid-derived extracellular vesicles from immobilized microgels for single-vesicle analysis.

  2022cites this paper
• Gallium: New developments and applications in radiopharmaceutics

  2021cites this paper
• The Relationship Between Mesenchymal Stem Cells and Tumor Dormancy

  2021cites this paper
• Chick Embryo Experimental Platform for Micrometastases Research in a 3D Tissue Engineering Model: Cancer Biology, Drug Development, and Nanotechnology Applications

  2021cites this paper
• Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response

  2021cites this paper
• Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy

  2021cites this paper
• Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas

  2021cites this paper
• Clusters, Assemblies and Aggregates of Tumor Cells in the Blood of Breast Cancer Patients; Composition, Mode of Action, Detection and Impact on Metastasis and Survival

  2021cites this paper
• Negative correlation of single-cell PAX3:FOXO1 expression with tumorigenicity in rhabdomyosarcoma

  2021cites this paper
• SHP2 inhibition enhances the anticancer effect of Osimertinib in EGFR T790M mutant lung adenocarcinoma by blocking CXCL8 loop mediated stemness

  2021cites this paper
• Characterization and clinicopathological significance of circulating tumour cells in patients with oral squamous cell carcinoma.

  2021cites this paper
• Virtual screening of potential anticancer drugs based on microbial products.

  2021cites this paper
• A new insight to deformability correlation of circulating tumor cells with metastatic behavior by application of a new deformability-based microfluidic chip.

  2021cites this paper
• SHP2 inhibition enhances the anticancer effect of Osimertinib in EGFR T790M mutant lung adenocarcinoma by blocking CXCL8 loop mediated stemness

  2021cites this paper
• Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice

  2021cites this paper
• Attenuated Microcirculation in Small Metastatic Tumors in Murine Liver

  2021cites this paper
• Cellular dormancy in minimal residual disease following targeted therapy

  2021cites this paper
• Recent progress in functional peptides designed for tumor-targeted imaging and therapy

  2021cites this paper
• Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells

  2021cites this paper
• Biomarkers for Precision Urothelial Carcinoma Diagnosis: Current Approaches and the Application of Single-Cell Technologies

  2021cites this paper
• The matrix in cancer

  2021cites this paper
• Targeting Histone Modifications in Bone and Lung Metastatic Cancers

  2021cites this paper
• Effect of Quercetin on ABCC6 Transporter: Implication in HepG2 Migration

  2021cites this paper
• HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer.

  2021cites this paper